TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

Tai chi could help ease depression, anxiety among stroke survivors

An eight-week tai chi course provided key benefits for older stroke survivors, researchers reported. 

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

Thumbnail

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

Thumbnail

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

TAVR, SAVR both beneficial for patients with low-gradient aortic stenosis

The new meta-analysis included data from 32 studies. 

Thumbnail

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI. 

STEMI following TAVR associated with high rates of mortality, PCI failure

The analysis, published in the Journal of the American College of Cardiology, found that post-TAVR STEMI might be rare, but it can lead to substantial complications. 

Apixaban appears safe for most TAVR patients, but questions remain

Researchers tracked data from more than 1,500 patients who underwent a successful TAVR procedure from 2016 to 2019. 

Displaying 337 - 344 of 401
Design by Adaptive Theme